TG Therapeutics Inc. (TGTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

TG Therapeutics Inc.

NASDAQ: TGTX · Real-Time Price · USD
36.70
0.04 (0.11%)
At close: Oct 03, 2025, 3:59 PM
36.66
-0.12%
After-hours: Oct 03, 2025, 07:33 PM EDT

TG Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
179.89M 92.93M 102.3M 298.89M
Short-Term Investments
131.11M 124.58M 59.37M 15.88M
Long-Term Investments
808K 1.28M 12.4M 35.53M
Other Long-Term Assets
3.37M 1.42M 1.27M 1.26M
Receivables
129.19M 51.09M n/a 1.39M
Inventory
110.46M 39.82M n/a -23.6M
Other Current Assets
15.72M 5.34M 2.36M 26.49M
Total Current Assets
566.36M 317.94M 168.27M 330.96M
Property-Plant & Equipment
7.15M 8.14M 10.82M 11.07M
Goodwill & Intangibles
n/a 799K 799K 799K
Total Long-Term Assets
11.33M 11.64M 25.3M 48.66M
Total Assets
577.69M 329.59M 193.57M 379.63M
Account Payables
58.3M 38.47M 42.02M 51.29M
Deferred Revenue
12.21M n/a 200K 457K
Short-Term Debt
661K n/a n/a 975K
Other Current Liabilities
3.17M 13.8M 969K 1.05M
Total Current Liabilities
90.68M 53.72M 53.2M 65.38M
Long-Term Debt
244.43M 100.12M 71.14M 66.79M
Other Long-Term Liabilities
n/a n/a 305K 457K
Total Long-Term Liabilities
264.65M 115.36M 81.78M 77.09M
Total Liabilities
355.33M 169.09M 134.99M 142.48M
Total Debt
254.38M 110.8M 83.06M 79.05M
Book Value
222.36M 160.5M 58.59M 237.15M
Book Value Per Share
1.53 1.13 0.43 1.79
Common Stock
156K 151K 146K 143K
Retained Earnings
-1.53B -1.51B -1.53B -1.33B
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
222.36M 160.5M 58.59M 237.15M
Total Investments
131.91M 124.58M 71.78M 51.41M